Reply to thread

When will the ARV7 biomarker test be available commercially? What company will be producing it? Little response to Xtandi or Zytiga if patient tests positive for ARV7. I'm sure the payers will pay for a test to show which metastatic prostate patients get no response to these expensive orals...